The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease

被引:1
|
作者
Irundika HK Dias [1 ]
Rachelle Taiwo [1 ]
Dan Ma [1 ]
机构
[1] Aston Medical School,College of Health and Life Sciences,Aston University
关键词
D O I
暂无
中图分类号
R749.16 [];
学科分类号
100203 ;
摘要
Alzheimer’s disease (AD) is a neurodegenerative disease that is characterized by an agedependent progressive decline of memory,impairment of cognitive functions and changes in personality and behavior.Despite the improvement in understanding of the mechanisms underlying the disease ,AD remains an incurable complex disorder with multifaceted pathophysiology to date.Apolipoprotein E (Apo E) is the main cholesterol carrier in the brain that supports lipid transport between brain cells.The individuals carrying the APOE4 allele are known to be at increased risk of developing AD compared with those carrying the more common APOE3 allele.
引用
收藏
页码:1973 / 1974
页数:2
相关论文
共 50 条
  • [31] Alzheimer's disease: future drug development and the blood-brain barrier
    Pardridge, William M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 569 - 572
  • [32] Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
    Gosselet, Fabien
    Saint-Pol, Julien
    Candela, Pietra
    Fenart, Laurence
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1015 - 1033
  • [33] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10): : 1500 - 1513
  • [34] Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease
    Rezai, Ali R.
    D'Haese, Pierre-Francois
    Finomore, Victor
    Carpenter, Jeffrey
    Ranjan, Manish
    Wilhelmsen, Kirk
    Mehta, Rashi I.
    Wang, Peng
    Najib, Umer
    Teixeira, Camila Vieira Ligo
    Arsiwala, Tasneem
    Tarabishy, Abdul
    Tirumalai, Padmashree
    Claassen, Daniel O.
    Hodder, Sally
    Haut, Marc W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (01): : 55 - 62
  • [35] Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
    Zipser, B. D.
    Johanson, C. E.
    Gonzalez, L.
    Berzin, T. M.
    Tavares, R.
    Hulette, C. M.
    Vitek, M. P.
    Hovanesian, V.
    Stopa, E. G.
    NEUROBIOLOGY OF AGING, 2007, 28 (07) : 977 - 986
  • [36] Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery
    Pardridge, William M.
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 25
  • [37] Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
    Simic, Goran
    Spanic, Ena
    Horvat, Lea Langer
    Hof, Patrick R.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 99 - 145
  • [38] Alzheimer's disease drug development and the problem of the blood-brain barrier
    Pardridge, William A.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 427 - 432
  • [39] Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease
    Lee, Rae-Ling
    Funk, Kristen E.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [40] The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
    Jeynes, Brian
    Provias, John
    JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (01) : 22 - 28